a Nexus Letter-a formal medical statement connecting the condition to service-can significantly improve approval odds. For veterans pursuing compensation, secondary conditions like sleep apnea or ...

The first medication for obstructive sleep apnea has been approved by the US Food and Drug Administration (FDA).

A hot potato: NZXT has responded to a damning video from YouTube channel Gamers Nexus that accuses the PC hardware giant of running a "predatory, evil rental computer scam." The program in ...

Sleep apnea is known to wreak havoc with the body, contributing to heart problems, diabetes and liver disease. The sleep disorder also appears to have direct effects on brain health, a new study ...

In the trial that Lilly, the drug's manufacturer, submitted in April to the FDA, scientists reported that the drug helped people who were overweight or obese with sleep apnea reduce a standard ...

Your tongue is a major component of your upper airway, and its size, structure, and function can be affected by — and contribute to — sleep apnea. Sleep apnea conditions cause pauses in your ...

For those who have tried unsuccessfully to use a CPAP machine to treat sleep apnea, the Inspire implant is a breakthrough ...

A custom, fitted mouthguard may be effective at managing sleep apnea or reducing its severity if CPAP therapy is not an option. Oral appliance therapy involves using specialized mouthguards to ...

Sleep apnea, a widespread health issue, causes breathing interruptions during sleep, leading to oxygen deprivation and various health problems. It manifests in obstructive, central, and mixed forms.

The Food and Drug Administration expanded the approval of weight loss drug Zepbound to treat obstructive sleep apnea in adults with obesity, the drugmaker Eli Lilly said Friday. The decision ...

GLP-1 Zepbound Is Approved As First Drug For Sleep Apnea By India Edwards HealthDay Reporter MONDAY, Dec. 23, 2024 (HealthDay News) -- The U.S. Food and Drug Administration (FDA) has approved the ...

Aside from obesity and sleep apnea, Lilly is also testing its tirzepatide franchise in other cardiometabolic conditions such as heart failure, prediabetes and metabolic dysfunction-associated ...